Wardlaw A J
Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London.
Clin Exp Allergy. 1993 Feb;23(2):81-96. doi: 10.1111/j.1365-2222.1993.tb00303.x.
Laboratory studies have clearly shown that inhalation of SO2 by asthmatics can cause a significant degree of wheezing at concentrations considerably lower than those which affect non-asthmatics. Concentrations as low as 0.2 p.p.m. have a significant effect, especially in subjects who are mouth breathing or undergoing heavy exercise. The effects of SO2 appear to be short-lived and not increased by more prolonged exposure (10 min versus 1 hr). WHO air quality guidelines on levels of SO2 have been based to a large extent on these studies and are set at or just below the reported threshold for effects on at risk groups. Thus the 1 hr recommended maximum is 0.16 p.p.m. (350 micrograms/m3). These guidelines have been exceeded in the U.K. on many occasions in the recent past [2] suggesting that asthmatics are at risk in high pollution areas from SO2 induced exacerbations of their asthma. This is particularly true considering that virtually all the laboratory studies have been performed on mild asthmatics. The effects on moderate and severe asthmatics, or those with marked lability of their asthma, could conceivably be seen at much lower concentrations of SO2. Similarly O3 can cause impairment in lung function at concentrations frequently detected in ambient air in the U.K. in both asthmatics and non-asthmatics with no evidence of an increased effect on asthmatics. This appears to be a restrictive rather than an obstructive defect. Ozone can also cause an increase in airways responsiveness to both non-specific bronchoconstrictors such as histamine and specific allergen. Both these effects are likely to be due to the pro-inflammatory effects of ozone and as such could be implicated both in exacerbating asthma through increased airway responsiveness and causing asthma through triggering an inflammatory reaction in the airways. No study has addressed the important question as to whether the incidence of bronchial hyperresponsiveness is increased in areas of high ozone pollution. The results with NO2 in the laboratory are equivocal. On balance the evidence suggests that any effect on asthmatics is likely to be small. Similarly while inhalation studies with acid aerosols have demonstrated some impairment in lung function in asthmatics the changes have been small and of brief duration. Laboratory studies while raising the level of suspicion and allowing dose response curves to be calculated cannot accurately mimic the effects of real air pollution with its combination of interacting circumstances and effects of prolonged exposure.(ABSTRACT TRUNCATED AT 400 WORDS)
实验室研究清楚地表明,哮喘患者吸入二氧化硫时,在浓度远低于影响非哮喘患者的水平时,就会引发显著程度的喘息。低至百万分之0.2的浓度就有显著影响,尤其是对那些用口呼吸或进行剧烈运动的人。二氧化硫的影响似乎是短暂的,延长暴露时间(10分钟与1小时)并不会增强这种影响。世界卫生组织关于二氧化硫水平的空气质量指南在很大程度上基于这些研究,设定在或略低于报告的对高危人群产生影响的阈值。因此,建议的1小时最大浓度为百万分之0.16(350微克/立方米)。在英国,最近这些指南多次被超过[2],这表明在高污染地区,哮喘患者有因二氧化硫诱发哮喘加重的风险。考虑到几乎所有的实验室研究都是在轻度哮喘患者身上进行的,情况尤其如此。可以想象,对于中度和重度哮喘患者或哮喘症状明显不稳定的患者,在更低的二氧化硫浓度下就可能出现影响。同样,在英国环境空气中经常检测到的浓度下,臭氧会导致哮喘患者和非哮喘患者的肺功能受损,没有证据表明对哮喘患者的影响会增强。这似乎是一种限制性而非阻塞性缺陷。臭氧还会导致气道对组胺等非特异性支气管收缩剂和特异性过敏原的反应性增加。这两种影响可能都归因于臭氧的促炎作用,因此可能既会通过增加气道反应性加重哮喘,又会通过引发气道炎症反应导致哮喘。没有研究探讨在高臭氧污染地区支气管高反应性的发生率是否会增加这一重要问题。实验室中关于二氧化氮的结果并不明确。总体而言,证据表明其对哮喘患者的任何影响可能都很小。同样,虽然对酸性气溶胶的吸入研究表明哮喘患者的肺功能有一些损害,但变化很小且持续时间很短。实验室研究虽然提高了怀疑程度并能计算剂量反应曲线,但无法准确模拟实际空气污染中相互作用的情况和长期暴露的影响。(摘要截选至400字)